Ute Galm is a seasoned professional in the fields of microbiology and bioprocessing with extensive experience in strain development and enzyme characterization. Currently serving as a Scientific Advisor at MeliBio since January 2024, Ute has previously held significant roles, including Vice President of Strain Development at Curie Co and Associate Director at Zymergen, Inc. Ute's expertise encompasses strategic planning, management of cross-functional projects, and development of innovative technologies such as CRISPR-Cas9 genome editing. A PhD holder in Pharmaceutical Biology from the University of Tübingen, Ute has also contributed to academia as a Postdoctoral Research Associate at the University of Wisconsin-Madison School of Pharmacy.
This person is not in any teams
This person is not in any offices